Tạp chí Tim mạch học Việt Nam

Article detail

Article detail description

Home
BÀI TỔNG QUAN Issue: Số 120 - 2026 CÁC CHỦ ĐỀ KHÁC (Xin vui lòng đề xuất trong mục Thư gửi Tổng biên tập)

Cardiovascular Disease in Advanced Maternal Age: The Role of Screening in the Management of High-Risk Pregnancy

Vũ Học Huấn: Bệnh viện Đa khoa Quốc tế Hải Phòng; Lê Thị Lương: Trung tâm Tim mạch, BV Đại học Y Hà Nội; Nguyễn Phương Tú: Bộ môn Phụ Sản, Trường Đại học Y Hà Nội; Phạm Nhật Minh: Bộ môn Tim mạch, Trường Đại học Y Hà Nội, Trung tâm Tim mạch, BV Đại học Y Hà Nội;
Published: May 7, 2026
Views: 78

Abstract

Cardiovascular disease during pregnancy is considered one of the major challenges of modern medicine because it directly affects the mother's life and profoundly impacts pregnancy outcomes and the long-term health of the newborn. Current evidence shows that complications caused by cardiovascular disease not only reflect the effects of physiological changes caused by pregnancy but also are a consequence of pre-existing damage or underlying cardiovascular disease. Early screening for cardiovascular risk factors in pregnant women, especially older women, will help limit and prevent serious cardiovascular events.

Keywords
cardiovascular disease in pregnancy cardiovascular risk screening maternal and fetal cardiovascular complications

References

1.
Lindley KJ. Call to action to address increasing maternal cardiovascular mortality in the United States: Strategies for improving maternal cardiovascular care. Circulation. 2022;145:502-504. doi:10.1161/CIRCULATIONAHA.121.057608
2.
Hameed AB, Lawton ES, McCain CL, Morton CH, Mitchell C, Main EK, Foster E. Pregnancy-related cardiovascular deaths in California: Beyond peripartum cardiomyopathy. Am J Obstet Gynecol. 2015;213(3):379.e1-379.e10. doi:10.1016/j.ajog.2015.05.008
3.
Vietnam National Heart Association. Proceedings of the 10th Southern Regional Cardiovascular Scientific Conference. 2011.
4.
European Society of Cardiology. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165-3241. doi:10.1093/eurheartj/ehy340
5.
American College of Obstetricians and Gynecologists. Pregnancy and heart disease. 2022.
6.
Vietnam National Heart Association. Guidelines for the management of cardiovascular diseases during pregnancy (adapted from ESC 2018). 2019.
7.
Chambers ME, De Zoysa MY, Hameed AB. Screening for cardiovascular disease in pregnancy: Is there a need? J Cardiovasc Dev Dis. 2022;9(3):89. doi:10.3390/jcdd9030089
8.
European Society of Cardiology. 2025 ESC guidelines for the management of cardiovascular disease and pregnancy. Eur Heart J. 2025. doi:10.1093/eurheartj/ehaf193
9.
Huyen HT, Nguyen MT. Heart disease in pregnant women: A 3-year retrospective study. Vietnam Med J. 2022;521(1):248-253.
10.
Hameed AB, Tarsa M, Graves CR, Grodzinsky A, Thiel de Bocanegra H, Wolfe DS. Universal cardiovascular disease risk assessment in pregnancy: Call to action from the JACC: Advances Expert Panel. JACC Adv. 2024;3(8):101055. doi:10.1016/j.jacadv.2024.101055
Cardiovascular Disease in Advanced Maternal Age: The Role of Screening in the Management of High-Risk Pregnancy

Files

Article Views78
Document Views9
Downloads0
Section BÀI TỔNG QUAN
Category CÁC CHỦ ĐỀ KHÁC (Xin vui lòng đề xuất trong mục Thư gửi Tổng biên tập)
Pages 57-63
Copyright Holder 2026 Tạp chí Tim mạch học Việt Nam